Literature DB >> 16787726

Suicide due to oral ingestion of lidocaine: a case report and review of the literature.

F Centini1, C Fiore, I Riezzo, G Rossi, V Fineschi.   

Abstract

The Authors describe a rare case of suicide in a 31-year-old woman, due to oral ingestion of lidocaine; the histological and toxicological findings are discussed to provide useful information to the present experience with this particular modality of death. Histological examination revealed generalized stasis. In the myocardium we observed segmentation of the myocardial cells and/or widening of intercalated discs and associated group of hypercontracted myocardial cells with "square" nuclei in line with hyperdistended ones. Non-eosinophilic bands of hypercontracted sarcomeres alternating with stretched, often apparently separated sarcomeres, small foci of paradiscal contraction band necrosis, and perivascular fibrosis were observed too. Lidocaine was detected in the subject's urine through immunoenzymatic screening. Toxicological analysis by solid-liquid extraction and gas chromatography-mass spectrometry (GC-MS) analysis, was carried out to identify and quantify the individual substances present in the biological fluids and organs. Lidocaine concentrations were as follows: blood 31 microg/mL, gastric content 2.5 g, liver 10 microg/g, kidney 12 microg/g, brain 9 microg/g, spleen 24 microg/g, lung 84 microg/g, heart 9 microg/g, urine 9 microg/mL, and bile 6 microg/mL. No other drugs or alcohol were detected. When blood lidocaine reaches toxic levels, serious toxic symptoms associated with the central nervous system and cardiac system are noted. The overdose of lidocaine produces death from ventricular fibrillation or cardiac arrest. In this case, according to macroscopic and microscopic findings, the cause of death was most likely cardiac and possibly related to ventricular fibrillation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16787726     DOI: 10.1016/j.forsciint.2006.05.003

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  8 in total

1.  Lidocaine (lignocaine) dosing regimen based upon a population pharmacokinetic model for preterm and term neonates with seizures.

Authors:  Marcel P H van den Broek; Alwin D R Huitema; Johan G C van Hasselt; Floris Groenendaal; Mona C Toet; Toine C G Egberts; Linda S de Vries; Catharine M A Rademaker
Journal:  Clin Pharmacokinet       Date:  2011-07       Impact factor: 6.447

2.  Lidocaine Infusion: An Antiarrhythmic With Neurologic Toxicities.

Authors:  Yasmeen M Daraz; Omar H Abdelghffar
Journal:  Cureus       Date:  2022-03-19

3.  Case Study of Fatal Stroke Following Intranasal Lidocaine.

Authors:  Daniel L Moellentin; Dale Stewart; James Barbour
Journal:  Hosp Pharm       Date:  2016-09

4.  Heated lidocaine/tetracaine patch for treatment of patellar tendinopathy pain.

Authors:  Arnold R Gammaitoni; Henry T Goitz; Stephanie Marsh; Thomas B Marriott; Bradley S Galer
Journal:  J Pain Res       Date:  2013-07-19       Impact factor: 3.133

5.  Lidocaine-Induced Systemic Toxicity: A Case Report and Review of Literature.

Authors:  Badar Hasan; Talal Asif; Maryam Hasan
Journal:  Cureus       Date:  2017-05-25

6.  Relevance of the drug-drug interactions between lidocaine and the pharmacokinetic enhancers ritonavir and cobicistat.

Authors:  Bart G J Dekkers; Wouter F W Bierman; Daan J Touw; Jan-Willem C Alffenaar
Journal:  AIDS       Date:  2019-05-01       Impact factor: 4.177

7.  Electrocorticographic description of the effects of anticonvulsant drugs used to treat lidocaine-induced seizures.

Authors:  George Francisco S Santos; Luan Oliveira Ferreira; Bruna Gerrits Mattos; Eliniete J Fidelis; Alisson S de Souza; Paula S Batista; Cecilia A F Manoel; Diego Arthur C Cabral; Vanessa Jóia de Mello; Dielly Catrina Favacho Lopes; Moisés Hamoy
Journal:  Brain Behav       Date:  2020-12-25       Impact factor: 3.405

8.  Acute Lidocaine Toxicity; a Case Series.

Authors:  Mitra Rahimi; Mahboubeh Elmi; Hossein Hassanian-Moghaddam; Nasim Zamani; Kambiz Soltaninejad; Reza Forouzanfar; Shahin Shadnia
Journal:  Emerg (Tehran)       Date:  2018-06-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.